The peptide binding motif of the disease associated HLA‐DQ (α 1* 0501, β 1* 0201) molecule
- 1 November 1996
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 26 (11) , 2764-2772
- https://doi.org/10.1002/eji.1830261132
Abstract
To identify the binding motifs of peptides which bind to the celiac disease and insulin-dependent-diabetes-mellitus (IDDM)-associated DQ2 molecule, peptides were eluted from affinity-purified DQ2 molecules. The eluted peptides were separated by reverse-phase HPLC. Prominent peptide peaks and the remaining pool of peptides were sequenced by Edman degradation. Truncated variants of eight different peptides with a length of 9–19 amino acids were identified; among them class II-associated invariant chain peptides (CLIP) and peptides that stem from HLA class I α, HLA-DQα1*0501, Ig and CD20 molecules. Data from the pool sequencing and the biochemical binding analyses of synthetic variants of an eluted high-affinity ligand (HLA class I α 46–60), indicate that the side chains of amino acid residues at relative position P1 (bulky hydrophobic), P4 (negatively charged or aliphatic), P6 (Pro or negatively charged), P7 (negatively charged) and P9 (bulky hydrophobic) are important for binding of peptides to DQ2. Computer modeling of the DQ2 with variants of the high-affinity ligand in the groove suggests that peptides bind to DQ2 through the primary anchors P1, P7 and P9 and making additional advantageous interactions using the P4 and P6 positions.Keywords
This publication has 25 references indexed in Scilit:
- The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3Nature, 1995
- Characterization of an HLA-DQ2-specific monoclonal antibody: Influence of amino acid substitutions in DQβ 1∗0202Human Immunology, 1995
- Receptor-ligand interactions measured by an improved spun column chromatography technique A high efficiency and high throughput size separation methodBiochimica et Biophysica Acta (BBA) - General Subjects, 1995
- Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II.The Journal of Experimental Medicine, 1995
- Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning.The Journal of Experimental Medicine, 1994
- Self-peptides bound to the type I diabetes associated class II MHC molecules HLA-DQ1 and HLA-DQ8International Immunology, 1994
- Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptideNature, 1994
- Identification of a motif for HLA-DR1 binding peptides using M13 display libraries.The Journal of Experimental Medicine, 1992
- Emerging Principles for the Recognition of Peptide Antigens by MHC Class I MoleculesScience, 1992
- Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in sizeNature, 1992